Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Ophthalmology Clerkship
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Research News
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • People First
  • Events
  • Giving
  • News

Neovascular AMD

DRCR AO

Posted on March 2, 2024

Home OCT-Guided Treatment versus Treat and Extend for the Management of Neovascular AMD (Protocol AO)

Posted in Actively Recruiting, Age-related Macular Degeneration, Clinical Trials, Kathleen Schildroth, Neovascular AMD

ATMOSPHERE

Posted on August 24, 2021

A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE)

Posted in Actively Recruiting, Age-related Macular Degeneration, Clinical Trials, Jonathan Chang, Neovascular AMDTagged gene therapy, neovascular age-related macular degeneration

PEP

Posted on August 24, 2021

Patient Experience and Preference (PEP) Study in nAMD and DME

Posted in Age-related Macular Degeneration, Clinical Trials, Diabetic Macular Edema, Mihai Mititelu, Neovascular AMD, Past

TALON

Posted on September 28, 2020

A 64-Week, Two-Arm, Randomized, Double-Masked, Multi-Center, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-To-Control Regimen in Patients with Neovascular Age-Related Macular Degeneration (TALON)

Posted in Age-related Macular Degeneration, Clinical Trials, Michael Altaweel, Neovascular AMD, Past

PULSAR

Posted on September 28, 2020

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients with Neovascular Age-Related Macular Degeneration (PULSAR)

Posted in Age-related Macular Degeneration, Clinical Trials, Mihai Mititelu, Neovascular AMD, Ongoing

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.